Last reviewed · How we verify

NCT04158284

Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts

Status unknown Last updated 7 March 2024
What this trial tests

trial in Craniopharyngioma in 90 participants. Status unknown.

Timeline
1 October 2019
Primary endpoint
30 June 2024
30 June 2024

Quick facts

Lead sponsorKlinikum Oldenburg gGmbH
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment90
Start date1 October 2019
Primary completion30 June 2024
Estimated completion30 June 2024
Sites1 location across Germany

Conditions studied

Sponsor

Klinikum Oldenburg gGmbH

Who can join

Adults 1 Day to 18, any sex, with Craniopharyngioma or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

KRANIOPHARYNGEOM Registry 2019 will prospectively collect and descriptively analyse data on diagnostics, treatment, and follow-up of patients with craniopharyngioma. In continuation of preceding studies also patients with xanthogranuloma, meningioma, pituitary adenoma, prolactinoma and cystic intracranial malformations will be registered.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Outcome after pediatric craniopharyngioma: the role of age at diagnosis and hypothalamic damage.
    Beckhaus J, Friedrich C, Boekhoff S, Calaminus G, et al · · 2023 · cited 26× · PMID 36857103 · DOI 10.1093/ejendo/lvad027
  2. Impact of parental body mass index at diagnosis on obesity in survivors of pediatric craniopharyngioma.
    Beckhaus J, Eveslage M, Bison B, Friedrich C, et al · · 2024 · cited 6× · PMID 38904467 · DOI 10.1530/ec-24-0126
  3. Daytime sleepiness and health-related quality of life in patients with childhood-onset craniopharyngioma.
    Mann-Markutzyk LV, Beckhaus J, Özyurt J, Mehren A, et al · · 2025 · cited 4× · PMID 40108339 · DOI 10.1038/s41598-025-94384-5
  4. Perinatally diagnosed congenital craniopharyngiomas in the KRANIOPHARYNGEOM trials.
    Beckhaus J, Boekhoff S, Scheinemann K, Schilling FH, et al · · 2023 · cited 3× · PMID 37878777 · DOI 10.1530/ec-23-0294
  5. Sporadic and neurofibromatosis type 2-associated meningioma in children and adolescents.
    Wagener K, Beckhaus J, Boekhoff S, Friedrich C, et al · · 2023 · cited 2× · PMID 37402092 · DOI 10.1007/s11060-023-04344-0
  6. Prolactin serum concentrations in childhood-onset craniopharyngioma patients.
    Sowithayasakul P, Beckhaus J, Özyurt J, Bison B, et al · · 2025 · PMID 40481916 · DOI 10.1007/s40618-025-02622-4

Verify or expand the search:

Other recruiting trials for Craniopharyngioma

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04158284.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing